EXAS vs HYNE · rev $2.76B vs P/E 408, rev $20.4M
EXACT Sciences Corporation (EXAS) versus Hoyne Bancorp, Inc. Common Stock (HYNE) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Hoyne Bancorp, Inc. Common Stock (HYNE) is a banks - regional company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported HYNE revenue for 2025-12-31 was $20.4M. Net income was $232.7K. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. HYNE currently screens at market cap $121.8M and trailing P/E 408.5.
EXAS currently screens at market cap $20.03B. HYNE currently screens at market cap $121.8M and trailing P/E 408.5.
Not investment advice. Open the EXAS and HYNE stock pages for the full models.
Not investment advice.